545393-67-7 Usage
Chemical class
Indole derivative
Explanation
1,3,3-Trimethylindolin-6-amine belongs to the indole class of organic compounds, which are heterocyclic compounds containing a benzene ring fused to a pyrrole ring.
Explanation
The compound has methyl groups attached to the 1, 3, and 3 positions of the indoline ring, which is a variation of the indole structure.
Explanation
Due to its unique structure and properties, 1,3,3-Trimethylindolin-6-amine is utilized in the synthesis of various pharmaceuticals and organic materials.
Explanation
Research has been conducted on the potential pharmacological activities of 1,3,3-Trimethylindolin-6-amine, including its possible use in treating cancer and inflammation.
Explanation
1,3,3-Trimethylindolin-6-amine has been studied for its potential use as a starting material in the synthesis of other complex organic molecules, due to its unique structure.
Explanation
The molecular formula of 1,3,3-Trimethylindolin-6-amine is C11H14N2, indicating that it consists of 11 carbon atoms, 14 hydrogen atoms, and 2 nitrogen atoms.
Explanation
The molecular weight of 1,3,3-Trimethylindolin-6-amine is around 174.24 grams per mole, which is a measure of the mass of one mole of the compound.
Explanation
Although not explicitly mentioned in the material, most organic compounds with similar structures are solids or crystalline at room temperature.
Explanation
The solubility of 1,3,3-Trimethylindolin-6-amine in various solvents is not provided in the material, but it can be inferred that it may be soluble in organic solvents like methanol, ethanol, or acetone, as is common for many organic compounds.
Explanation
The material does not specify the stability of 1,3,3-Trimethylindolin-6-amine under different conditions, such as temperature, light, or exposure to air. Further research or information would be needed to determine its stability.
Structural features
Methyl groups on the 1, 3, and 3 positions
Synthesis
Used in the synthesis of pharmaceuticals and organic materials
Pharmacological activities
Investigated for anti-cancer and anti-inflammatory properties
Precursor
Potential use as a precursor in the synthesis of complex organic molecules
Molecular weight
Approximately 174.24 g/mol
Appearance
Likely a solid or crystalline substance
Solubility
Solvent compatibility is not specified in the material
Stability
Stability information is not provided in the material
Check Digit Verification of cas no
The CAS Registry Mumber 545393-67-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,4,5,3,9 and 3 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 545393-67:
(8*5)+(7*4)+(6*5)+(5*3)+(4*9)+(3*3)+(2*6)+(1*7)=177
177 % 10 = 7
So 545393-67-7 is a valid CAS Registry Number.
545393-67-7Relevant academic research and scientific papers
HETEROCYCLE-SUBSTITUTED CYCLIC UREA DERIVATIVES, PREPARATION THEREOF AND PHARMACEUTICAL USE THEREOF AS KINASE INHIBITORS
-
Page/Page column 101, (2010/02/15)
The invention relates to the novel products of formula (I), in which V represents a heterocyclic radical, as protein kinases inhibitors.
Vanilloid receptor ligands and their use in treatments
-
, (2008/06/13)
Compounds having the general structure and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritis, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.
